← Evidence map

ReviewPharmacogenomics2016

Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment.

Lydia Wt Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

39 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26807692